BOCGI Zheshang Capital logo

BOCGI Zheshang Capital

Asia, Zhejiang, China, Hangzhou

Description

BOCGI Zheshang Capital is an investment firm.

Investor Profile

BOCGI Zheshang Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Private Equity (50%)

Country Focus

  • China (50%)
  • United States (50%)

Industry Focus

  • Health Care
  • Biopharma
  • Biotechnology
  • Medical
  • Pharmaceutical
  • 3d Technology
  • Health Diagnostics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BOCGI Zheshang Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
MV
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Draper Dragon
North America, California, United States, San Mateo
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Taikang Asset
Asia, Beijing, China, Beijing
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 1
3F
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by BOCGI Zheshang Capital?

EDDA Technology

Princeton, New Jersey, United States

EDDA Technology offers computer assistance to the patient care management cycle and enables early detection and diagnosis of diseases.

3D TechnologyHealth CareHealth DiagnosticsInformation Technology
Private EquityApr 7, 2021
Amount Raised: $150,000,000

Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJun 6, 2018
Amount Raised: $35,000,000